Loading clinical trials...
Loading clinical trials...
Hypothesis 1. To define whether stimulation of ATGL and suppression of G0/G1 switch gene occur in the initial phases of diabetic ketoacidosis and thus can be identified as the primary mechanisms behi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Aarhus
NCT06575426 · Diabetes Mellitus, Type 1, Hypoglycemia, and more
NCT06936280 · Diabetes Distress, Diabetes Mellitus Type 1
NCT06955416 · Diabetic Ketoacidosis
NCT06115876 · Diabetes Mellitus Type 2, Diabetes Mellitus Type 1, NAFLD - Nonalcoholic Fatty Liver Disease, and more
NCT06186245 · Diabetes Mellitus, Diabetic Ketoacidosis
Aarhus University Hospital
Aarhus
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions